131 related articles for article (PubMed ID: 8017447)
21. Disseminated histoplasmosis in persons infected with human immunodeficiency virus.
Hajjeh RA
Clin Infect Dis; 1995 Aug; 21 Suppl 1():S108-10. PubMed ID: 8547497
[TBL] [Abstract][Full Text] [Related]
22. Successful discontinuation of secondary prophylaxis for histoplasmosis after highly active antiretroviral therapy.
Sun HY; Chen MY; Hsieh SM; Hung CC; Chang SC
J Formos Med Assoc; 2004 Jul; 103(7):546-8. PubMed ID: 15318277
[TBL] [Abstract][Full Text] [Related]
23. Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
Viviani MA
Chemotherapy; 1992; 38 Suppl 1():35-42. PubMed ID: 1319314
[TBL] [Abstract][Full Text] [Related]
24. Histoplasmosis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): multicenter study of outcomes and factors associated with relapse.
Myint T; Anderson AM; Sanchez A; Farabi A; Hage C; Baddley JW; Jhaveri M; Greenberg RN; Bamberger DM; Rodgers M; Crawford TN; Wheat LJ
Medicine (Baltimore); 2014 Jan; 93(1):11-18. PubMed ID: 24378739
[TBL] [Abstract][Full Text] [Related]
25. A case of HIV-associated cerebral histoplasmosis successfully treated with fluconazole.
Knapp S; Turnherr M; Dekan G; Willinger B; Stingl G; Rieger A
Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):658-61. PubMed ID: 10534189
[TBL] [Abstract][Full Text] [Related]
26. Comparison of fluconazole with amphotericin B in treatment of histoplasmosis in normal and immunosuppressed mice.
Kobayashi GS; Travis SJ; Medoff G
Rev Infect Dis; 1990; 12 Suppl 3():S291-3. PubMed ID: 2330487
[TBL] [Abstract][Full Text] [Related]
27. Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole.
Wheat LJ; Cloud G; Johnson PC; Connolly P; Goldman M; Le Monte A; Fuller DE; Davis TE; Hafner R; ;
Antimicrob Agents Chemother; 2001 Aug; 45(8):2354-7. PubMed ID: 11451696
[TBL] [Abstract][Full Text] [Related]
28. [A case of acquired immunodeficiency syndrome (AIDS) with histoplasmosis].
Aso Y; Pae Y; Hayashi J; Kashiwagi S; Takemori K
Kansenshogaku Zasshi; 1999 Dec; 73(12):1227-31. PubMed ID: 10655685
[TBL] [Abstract][Full Text] [Related]
29. Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infection.
Haynes RR; Connolly PA; Durkin MM; LeMonte AM; Smedema ML; Brizendine E; Wheat LJ
J Infect Dis; 2002 Jun; 185(12):1830-2. PubMed ID: 12085335
[TBL] [Abstract][Full Text] [Related]
30. Oral voriconazole therapy in cats with histoplasmosis yielded mild side effects and a favorable outcome.
Easterwood LF; Harkin KR; Rankin AJ
J Am Vet Med Assoc; 2023 Nov; 261(11):1-5. PubMed ID: 37524351
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
[TBL] [Abstract][Full Text] [Related]
32. A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil.
Brilhante RSN; Guedes GMM; Silva MLQD; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
Int J Antimicrob Agents; 2018 Aug; 52(2):272-277. PubMed ID: 29592837
[TBL] [Abstract][Full Text] [Related]
33. Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome.
Sugar AM; Saunders C
Am J Med; 1988 Oct; 85(4):481-9. PubMed ID: 2845779
[TBL] [Abstract][Full Text] [Related]
34. Histoplasmosis in HIV-positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates.
Brilhante RS; Fechine MA; Mesquita JR; Cordeiro RA; Rocha MF; Monteiro AJ; Lima RA; Caetano ÉP; Pereira JF; Castelo-Branco DS; Camargo ZP; Sidrim JJ
Trans R Soc Trop Med Hyg; 2012 Aug; 106(8):484-8. PubMed ID: 22703696
[TBL] [Abstract][Full Text] [Related]
35. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
Saag MS; Powderly WG; Cloud GA; Robinson P; Grieco MH; Sharkey PK; Thompson SE; Sugar AM; Tuazon CU; Fisher JF
N Engl J Med; 1992 Jan; 326(2):83-9. PubMed ID: 1727236
[TBL] [Abstract][Full Text] [Related]
36. [Disseminated histoplasmosis treated by boluses of fluconazole].
Mandengue Ebenye C; Takuefou Mfangam B; Nouédoui C; Atangana PJ
Med Sante Trop; 2015; 25(1):110-1. PubMed ID: 24854365
[TBL] [Abstract][Full Text] [Related]
37. Histoplasmosis in Indianapolis.
Wheat LJ
Clin Infect Dis; 1992 Mar; 14 Suppl 1():S91-9. PubMed ID: 1314107
[TBL] [Abstract][Full Text] [Related]
38. Amphotericin B combined with itraconazole or fluconazole for treatment of histoplasmosis.
LeMonte AM; Washum KE; Smedema ML; Schnizlein-Bick C; Kohler SM; Wheat LJ
J Infect Dis; 2000 Aug; 182(2):545-50. PubMed ID: 10915087
[TBL] [Abstract][Full Text] [Related]
39. Fluconazole therapy for histoplasmosis. The National Institute of Allergy and Infectious Diseases Mycoses Study Group.
McKinsey DS; Kauffman CA; Pappas PG; Cloud GA; Girard WM; Sharkey PK; Hamill RJ; Thomas CJ; Dismukes WE
Clin Infect Dis; 1996 Nov; 23(5):996-1001. PubMed ID: 8922792
[TBL] [Abstract][Full Text] [Related]
40. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy.
Goldman M; Zackin R; Fichtenbaum CJ; Skiest DJ; Koletar SL; Hafner R; Wheat LJ; Nyangweso PM; Yiannoutsos CT; Schnizlein-Bick CT; Owens S; Aberg JA;
Clin Infect Dis; 2004 May; 38(10):1485-9. PubMed ID: 15156489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
